Annual Working Capital
-$543.00 K
-$6.20 M-109.60%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual working capital is -$543.00 thousand, with the most recent change of -$6.20 million (-109.60%) on December 1, 2023.
- During the last 3 years, NRSN annual working capital has fallen by -$1.19 million (-184.06%).
- NRSN annual working capital is now -105.02% below its all-time high of $10.81 million, reached on December 31, 2021.
Performance
NRSN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$3.00 M
-$1.11 M-58.71%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly working capital is -$3.00 million, with the most recent change of -$1.11 million (-58.71%) on September 1, 2024.
- Over the past year, NRSN quarterly working capital has increased by +$345.00 thousand (+10.32%).
- NRSN quarterly working capital is now -123.42% below its all-time high of $12.80 million, reached on March 31, 2022.
Performance
NRSN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NRSN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -109.6% | +10.3% |
| 3 y3 years | -184.1% | -128.9% |
| 5 y5 years | -162.0% | - |
NRSN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -105.0% | at low | -123.4% | +10.3% |
| 5 y | 5-year | -105.0% | at low | -123.4% | +10.3% |
| alltime | all time | -105.0% | at low | -123.4% | +10.3% |
NeuroSense Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$3.00 M(+58.7%) |
| Jun 2024 | - | -$1.89 M(-43.5%) |
| Mar 2024 | - | -$3.34 M(+515.7%) |
| Dec 2023 | -$543.00 K(-109.6%) | -$543.00 K(-123.6%) |
| Sep 2023 | - | $2.30 M(-49.6%) |
| Jun 2023 | - | $4.56 M(+41.3%) |
| Mar 2023 | - | $3.23 M(-43.0%) |
| Dec 2022 | $5.66 M | $5.66 M(-30.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.08 M(-22.1%) |
| Jun 2022 | - | $10.37 M(-19.0%) |
| Mar 2022 | - | $12.80 M(+18.4%) |
| Dec 2021 | $10.81 M(+1574.1%) | - |
| Dec 2021 | - | $10.81 M(+1122.0%) |
| Jun 2021 | - | $885.00 K(+37.0%) |
| Dec 2020 | $646.00 K(-26.3%) | $646.00 K |
| Dec 2019 | $876.00 K | - |
FAQ
- What is NeuroSense Therapeutics annual working capital?
- What is the all time high annual working capital for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual working capital year-on-year change?
- What is NeuroSense Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly working capital year-on-year change?
What is NeuroSense Therapeutics annual working capital?
The current annual working capital of NRSN is -$543.00 K
What is the all time high annual working capital for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual working capital is $10.81 M
What is NeuroSense Therapeutics annual working capital year-on-year change?
Over the past year, NRSN annual working capital has changed by -$6.20 M (-109.60%)
What is NeuroSense Therapeutics quarterly working capital?
The current quarterly working capital of NRSN is -$3.00 M
What is the all time high quarterly working capital for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly working capital is $12.80 M
What is NeuroSense Therapeutics quarterly working capital year-on-year change?
Over the past year, NRSN quarterly working capital has changed by +$345.00 K (+10.32%)